Pulgo, Jemson E.

HRN: 24-31-27  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2023
CEFTRIAXONE 1G (VIAL)
12/30/2023
01/05/2024
IV
2g
OD
Cap Mr
Checking Final Appropriateness 
12/31/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/31/2023
01/06/2024
IVT
4.5g
Q8
Hyperglycemic Crisis; CAP MR
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: